Post by
antigua1987 on Dec 13, 2021 3:52pm
Along the lines of giving credit where it's due or not,
...M Jasmin, who has delivered many o' tossed salad at SH readers, was hired as IR senior director in Dec/18, when SP was CAD7$+ and oncology investor optimism was near all time peak (covid head fake excluded). Curious as to where he thought IMV was heading at that time.
So in 3 yrs, his overall contribution has not developed needed support to get us beyond today's CAD1.75$. Well below latest PP, in fact. That is an absolute 75% loss in share value in his 3 yrs. It's not the only metric, but it is the ultimate metric. Move on MJ - if only to reduce drag on new SVP IR.
If any one has them, please list his wins.